{"id":2083,"date":"2016-12-01T06:41:01","date_gmt":"2016-12-01T06:41:01","guid":{"rendered":"http:\/\/europeanvenousforum.org\/?page_id=2083"},"modified":"2018-02-16T05:34:08","modified_gmt":"2018-02-16T05:34:08","slug":"17th-evf-london-scientific-programme","status":"publish","type":"page","link":"https:\/\/europeanvenousforum.org\/index.php\/17th-evf-london-scientific-programme\/","title":{"rendered":"17th EVF London Scientific Programme"},"content":{"rendered":"

Provisional Scientific Programme<\/strong><\/span><\/h2>\n

17th<\/sup> Meeting of the European Venous Forum <\/strong><\/span><\/p>\n

In collaboration with the UK Venous Forum, Royal Society of Medicine<\/strong><\/span><\/p>\n

London, UK, 7- 9 July 2016<\/strong><\/span><\/p>\n

Click here<\/a> to download the Programme.<\/span><\/h5>\n
Click here<\/a> to download the Programme\/Book of Abstracts.<\/span><\/h5>\n

 <\/p>\n

THURSDAY 7 JULY 2016<\/strong><\/span><\/h2>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08.30-10.30<\/span><\/td>\nAbstract Session 1:<\/strong><\/span> Risk Prediction and Superficial Vein Thrombosis (10 minute presentation, 5 minute discussion)<\/span><\/p>\n

Chair: Andrew Bradbury (UK), Gerry Stansby (UK)<\/em><\/span><\/td>\n<\/tr>\n

08.30 <\/span>Paper 1.1<\/td>\nMean platelet volume (MPV) as a predictor of venous thromboembolism (VTE) in colorectal cancer. C Wilasrusmee1<\/sup>, B Siribumrungwong2<\/sup>, N Poprom1<\/sup><\/em><\/span><\/p>\n

1<\/sup>Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2<\/sup>Department of Surgery, Faculty of Medicine, Thammasat University Hospital, Thammasat University, Pathumthani, Thailand<\/span><\/td>\n<\/tr>\n

08.45<\/span> Paper 1.2<\/td>\nThe agreement between Caprini and Department of Health venous thromboembolism risk scores in urological patients. M Karia, S Onida, Alun H Davies<\/em><\/span><\/p>\n

Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

09.00<\/span> Paper 1.3<\/td>\nRisk adjusted DVT prophylaxis for ambulatory varicose vein procedures: How useful is the Caprini risk assessment model? AJ Wagstaff, SJ Goodyear, IK Nyamekye<\/em><\/span><\/p>\n

The Vascular Unit, Worcestershire Royal Hospital. UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

09.15<\/span> Paper 1.4<\/td>\nVTE assessment scoring in patients undergoing superficial venous intervention.\u00a0 US and UK perspectives on risk stratification. S Onida1<\/sup>, M Karia1, Grant Y1<\/sup>, Bootun R1<\/sup>, Najem M2<\/sup>, Shalhoub J1, Davies AH1<\/sup><\/em><\/span><\/p>\n

1<\/sup>Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, UK; 2<\/sup>North West London Hospitals NHS Trust, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

09.30 <\/span>Paper 1.5<\/td>\nPatterns in the management of superficial vein thrombosis. C Karathanos1<\/sup>, K Spanos1<\/sup>, V Lachanas2<\/sup>, A Athanasoulas1<\/sup>, AD Giannoukas1<\/sup><\/em><\/span><\/p>\n

1 <\/sup>Department of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece; 2<\/sup> Department of\u00a0 Otorhinolaryngology, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece<\/span><\/td>\n<\/tr>\n

09.45 <\/span>Paper 1.6<\/td>\nRivaroxaban for thrombosis prophylaxis in endovenous laser ablation with and without miniphlebectomy: A multicentre experience. H Uthoff1,2<\/sup>, D Holtz3<\/sup>, L Spinedi1<\/sup>, P Broz4<\/sup>, D Staub<\/em>1<\/em> <\/sup><\/span><\/p>\n

1<\/sup> Department of Angiology, University Hospital, Basel, Switzerland; 2<\/sup> Gefaesspraxis am See, St. Anna im Bahnhof, Lucerne, Switzerland; 3<\/sup> Vascular Clinic, Rapperswil, Rapperswil, Switzerland; 4<\/sup> Department of Angiology, Hospital of Limmattal, Limmattal, Switzerland<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

10.00<\/span> Paper 1.7<\/td>\nTreatment of superficial vein thrombosis with intermediate does of tinzaparin.\u00a0 The Seven study. C Karathanos1<\/sup><\/em>,A Giannoukas1<\/sup>, S Kakkos2<\/sup>, G Georgiadis3<\/sup>, C Maltezos4<\/sup>, M Matsagkas5<\/sup>, G.Papadopoulos6<\/sup>, C Ioannou6<\/sup>, K Spanos1<\/sup>, S Mastoraki7<\/sup>, S Vasdekis7<\/sup>, G Trelopoulos8<\/sup>, M Lazarides3<\/sup>, I Tsolakis2<\/sup><\/em><\/span><\/p>\n

1<\/sup>Department of Vascular Surgery, University Hospital of Larissa, Greece; 2<\/sup>Department of Vascular Surgery, University Hospital of Patras, Greece; 3<\/sup>Department of Vascular Surgery, University Hospital of Alexandroupolis, Greece; 4<\/sup>Department of Vascular Surgery, “KAT” Hospital, Athens, Greece; 5<\/sup>Vascular Surgery Unit, Department of Surgery, University Hospital of Ioannina, Greece; 6<\/sup>Department of Vascular Surgery, University Hospital of Heraklion, Crete, Greece; 7<\/sup>Department of Vascular Surgery, “ATTIKON” University Hospital, Athens; 8<\/sup>Vascular Surgery Unit, Department of Cardio-Thoracic Surgery, “Papanikolaou” Hospital, Thessaloniki, Greece<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

10.15<\/span> Paper 1.8<\/td>\nDeep venous stenting. A single centre experience. M Harris1<\/sup>, A Busuttil1,2<\/sup>, N Burfitt1<\/sup>, R Thomas1<\/sup>, AH Davies1,2<\/sup><\/em><\/span><\/p>\n

1<\/sup>Imperial College Healthcare NHS Trust, London, UK; 2<\/sup>Imperial College London, London, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

10.30-11.00<\/span><\/td>\nRefreshments and visit to Exhibition\u00a0 |\u00a0 ePresentations Session<\/span><\/td>\n<\/tr>\n
11.00-12.00<\/span><\/td>\nDidactic Session 1:<\/strong><\/span><\/p>\n

Sulodexide (Alfa Wassermann)<\/em>
\n<\/span><\/p>\n

Chairmen: Andrew Nicolaides (Cyprus), Giuseppe Maria Andreozzi (Italy)
\n<\/em><\/span><\/td>\n<\/tr>\n

11.00<\/span><\/td>\nBiomarkers in chronic venous disease and deep vein thrombosis. Ferdinando Mannello (Italy)<\/em><\/span><\/td>\n<\/tr>\n
11.15<\/span><\/td>\nSulodexide in chronic venous disease and prevention of DVT recurrence.\u00a0Tomasz Urbanek (Poland)<\/em><\/span><\/td>\n<\/tr>\n
11.30<\/span><\/td>\nPharmacological rationale behind the clinical effects of Sulodexide. Jawed Fareed (USA)<\/em><\/span><\/td>\n<\/tr>\n
11.45<\/span><\/td>\nDiscussion<\/strong><\/span> Moderator: Andrew Nicolaides (Cyprus)<\/span><\/em><\/td>\n<\/tr>\n
12.00-13.00<\/span><\/td>\nDidactic Session 2:<\/strong><\/span><\/p>\n

Acute DVT<\/span><\/p>\n

UK Venous Forum<\/span><\/p>\n

Chairmen: Athanasios Giannoukas (Greece), Manj Gohel (UK)
\n<\/em><\/span><\/td>\n<\/tr>\n

12.00<\/span><\/td>\nRole of D-dimer, duplex and scoring systems for VTE. Katy Darvall (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.10<\/span><\/td>\nInvestigating DVT patients for cancer. Roshan Agarwal (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.20<\/span><\/td>\nTreating cancer patients with DVT. Andy Wigham (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.30<\/span><\/td>\nModern treatment of acute deep vein thrombosis. Stephen Black (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.40<\/span><\/td>\nDiscussion<\/span><\/strong><\/td>\n<\/tr>\n
13.00-14.00<\/span><\/td>\nLunch and visit to Exhibition\u00a0 |\u00a0 ePresentations Session<\/span><\/td>\n<\/tr>\n
14.00-16.00<\/span><\/td>\nDidactic Session 3:<\/strong><\/span><\/p>\n

UK Venous Forum and the British Association of Sclerotherapy<\/span><\/p>\n

Chairmen: Philip Coleridge-Smith (UK), Issac Nyamekye (UK)
\n<\/em><\/span><\/td>\n<\/tr>\n

14.00<\/span><\/td>\nWhat is the best technique of sclerotherapy for telangiectasiae and reticular varices? Albert A Ramelet (Switzerland)<\/em><\/span><\/td>\n<\/tr>\n
14.10<\/span><\/td>\nEvidence for the use of compression after sclerotherapy for telangiectasiae and for saphenous trunks. Claudine Hamel-Desnos (France)<\/em><\/span><\/td>\n<\/tr>\n
14.20<\/span><\/td>\nVenous symptoms and the SymVein consensus. Michel Perrin (France)<\/em><\/span><\/td>\n<\/tr>\n
14.30<\/span><\/td>\nComplications of foam and liquid sclerothepray and how to avoid them. Jean-Jerome Guex (France)<\/em><\/span><\/td>\n<\/tr>\n
14.40<\/span><\/td>\nDiscussion<\/span><\/strong><\/td>\n<\/tr>\n
15.00<\/span><\/td>\nPhlebectomies vs foam for tributaries: Which is best and when. Dan Carradice (UK)<\/em><\/span><\/td>\n<\/tr>\n
15.10<\/span><\/td>\nDoctor, when can I fly? Sarah Onida (UK)<\/em><\/span><\/td>\n<\/tr>\n
15.20<\/span><\/td>\nPros and cons of endovenous glue. Sudip Ray (UK)<\/em><\/span><\/td>\n<\/tr>\n
15.30<\/span><\/td>\nPros and cons of MOCA (Clarivein). Peter Holt (UK)<\/em><\/span><\/td>\n<\/tr>\n
15.40<\/span><\/td>\nDiscussion<\/span><\/strong><\/td>\n<\/tr>\n
16.00-16.30<\/span><\/td>\nRefreshments and visit to Exhibition\u00a0 |\u00a0 ePresentations Session<\/span><\/td>\n<\/tr>\n
16.30-17.30<\/span><\/td>\nDidactic Session 4:<\/strong><\/span><\/p>\n

Lymphoedema (Sigvaris)<\/em>
\n<\/span><\/p>\n

Chairmen: Christine\u00a0 Moffat (UK), Sophie Renton (UK)
\n<\/em><\/span><\/td>\n<\/tr>\n

17.30-18.00<\/span><\/td>\nChairman: Andrew Bradbury (UK)<\/em><\/span><\/p>\n

Invited Key-Note Lecture<\/span><\/p>\n

The state of art, and the future of truncal ablation<\/span><\/p>\n

Lowell Kabnick, President, American Venous Forum<\/em><\/span><\/td>\n<\/tr>\n

18.00<\/span><\/td>\nWelcome Reception. Exhibition Area<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n

FRIDAY 8 JULY 2016<\/span><\/strong><\/h2>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08.30-10.30<\/span><\/td>\nAbstract Session 2:<\/strong> Varicose Vein Ablation (10 minute presentation, 5 minute discussion)<\/p>\n

Chair: Marianne Vandendrissche (Belgium), Ian Franklin (UK)<\/em><\/td>\n<\/tr>\n

08.30<\/span> Paper 2.1<\/span><\/td>\nEndovenous heat-induced thrombosis after endovenous laser ablation with 1470 NM laser and radial fibres. OP Mandzhikian1,2,3<\/sup>, DN Morenko2,3,4<\/sup>, EA Letunovskiy1<\/sup>, IA Kutidze3,4<\/sup>, AV Zherdev1<\/sup>, KA Kaperiz1<\/sup>, AM Isaev 2,3<\/sup><\/em><\/span><\/p>\n

1<\/sup>\u201cCenter of Laser Surgery\u201d, Moscow, Russia; 2<\/sup>\u201cGarant Clinic\u201d, Moscow, Russia; 3 <\/sup>Moscow State First Medical University Hospital #4, Moscow, Russia; 4<\/sup>\u201cPlastic-C\u201d, Korolev, Russia<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

08.45<\/span> Paper 2.2<\/span><\/td>\nPercutaneous ligation of the GSV with ultrasound guided foam sclerotherapy and miniphlebectomies. J Lawaetz, <\/em><\/span>L Rasmussen<\/em><\/p>\n

The Danish Vein Centres, Copenhagen Denmark<\/span><\/td>\n<\/tr>\n

09.00<\/span> Paper 2.3<\/span><\/td>\nNovel biomatrix sclerofoam compared to endovenous laser \u2013 initial results and one year follow up. Ragg JC<\/em><\/span><\/p>\n

Angioclinic Vein Centres – Interventional Phlebology, Berlin \u2013 Munich, Germany, \u2013 Zurich, Switzerland<\/span><\/td>\n<\/tr>\n

09.15<\/span> Paper 2.4<\/span><\/td>\nThe impact on residual venous reflux and varicose vein at one month follow-up on the development of recurrence of varicose vein after 5 years saphenous ablation for primary varicose vein. T Ogawa, S Hoshino<\/em><\/span><\/p>\n

Cardiovascular Surgery, Fukushima Daiichi Hospital, Fukushima, Japan<\/span><\/td>\n<\/tr>\n

09.30<\/span> Paper 2.5<\/span><\/td>\nA comparison of five year treatment outcomes in patients with and without complications of superficial venous insufficiency. J El-Sheikha, S Nandhra, C Leung, T Wallace, D Carradice, I Chetter<\/em><\/span><\/p>\n

Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

09.45<\/span> Paper 2.6<\/span><\/td>\nMechanochemial ablation (MOCA) in patients with severe superficial vein incompetence.\u00a0 A prospective report. M \u00c5kesson, A Lundell<\/em><\/span><\/p>\n

Venous Centre, Malm\u00f6, Sweden<\/span><\/td>\n<\/tr>\n

10.00<\/span> Paper 2.7<\/span><\/td>\nRandomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: The multicentre Venefit versus Clarivein for varicose veins (VVCVV) Trial. R Bootun1<\/sup>, TRA Lane1<\/sup>, B Dharmarajah1<\/sup>, CS Lim1,2<\/sup>, M Najem2<\/sup>, S Renton2<\/sup>, K Sritharan1<\/sup>, AH Davies1<\/sup><\/em><\/span><\/p>\n

1<\/sup>Academic Section of Vascular Surgery, Imperial College London, London, United Kingdom; 2<\/sup>Department of Vascular Surgery, North West London Hospitals NHS Trust, Harrow, United Kingdom<\/span><\/td>\n<\/tr>\n

10.15<\/span> Paper 2.8<\/span><\/td>\nCyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression:\u00a0 A post-market evaluation of the venaseal system (WAVES trial).\u00a0 Preliminary one month data. K Gibson, on behalf of the WAVES investigators<\/em><\/span><\/p>\n

Lake Washington Vascular Surgeons, Bellevue, Washington, USA<\/span><\/td>\n<\/tr>\n

10.30-11.00<\/span><\/td>\nRefreshments and visit to Exhibition\u00a0 |\u00a0 ePresentations Session<\/span><\/td>\n<\/tr>\n
11.00-12.00<\/span><\/td>\nDidactic Session 5:<\/strong> The place of ruscus extract + HMC + VitC in the management of chronic venous disease. (Pierre Fabre)<\/em>
\n<\/span>Chairmen: Andrew Nicolaides (Cyprus), Pavel Poredos (Slovenia)
\n<\/em><\/span><\/td>\n<\/tr>\n
11.00-11.15<\/span><\/td>\nMuscarinic receptors in chronic venous disease and the effect of Ruscus.<\/span> Eliete Bouskela (Brazil)<\/span><\/em><\/td>\n<\/tr>\n
11.15-11.30<\/span><\/td>\nChronic venous disease pathophysiology update. Arkadiusz Jawien (Poland)<\/em><\/span><\/td>\n<\/tr>\n
11.30-11.45<\/span><\/td>\nUpdate on Ruscus extract + HMC + VitC comprehensive mode of action and efficacy. Francois-Andr\u00e9 Allaert (France)<\/em><\/span><\/td>\n<\/tr>\n
11.45-12.00<\/span><\/td>\nPanel Discussion and Conclusions<\/span><\/td>\n<\/tr>\n
12.00-13.00<\/span><\/td>\nAbstract Session 3:<\/strong><\/span> Cost-benefit Studies, Epidemiology and Anticoagulation Complications (10 minute presentation, 5 minute discussion)<\/span><\/p>\n

Chair: Marianne De Maeseneer (Belgium), Keith Poskitt (UK)<\/span><\/em><\/td>\n<\/tr>\n

12.00<\/span> Paper 3.1<\/span><\/td>\nA cost comparison of treating those with and without the complications of SVI. J El-Sheikha, S Nandhra, C Leung, T Wallace, D Carradice, I Chetter<\/em><\/span><\/p>\n

Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

12.15<\/span> Paper 3.2<\/span><\/td>\nThe relationship between social deprivation and referral to a vascular service for the assessment and diagnosis of varicose veins and leg ulcer before and after publication of NICE Clinical Guidelines 168. H Davies, M Popplewell, A Koutsoumpelis, G Bate, A Bradbury<\/em><\/span><\/p>\n

University of Birmingham Department of Vascular Surgery, Heart of England NHS Foundation Trust, Birmingham, UK<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

12.30<\/span> Paper 3.3<\/span><\/td>\nThe prevalence of chronic venous disease worldwide.\u00a0 An epidiomological analysis.\u00a0 The final results of the vein consult programme. D Van Quickenborne1<\/sup>, R Colman2<\/sup>, S Thomis3<\/sup>, G Guillaume4<\/sup>, I Staelens5<\/sup>, ME Vuylsteke1<\/sup><\/em><\/span><\/p>\n

1 <\/sup>Department of Vascular Surgery, Sint-Andriesziekenhuis Tielt Belgium; 2\u00a0 <\/sup>Department of Public Health, Biostatistics unit, University of Ghent, Ghent, Belgium; 3 <\/sup>Department of Vascular Surgery, University hospitals Leuven, Belgium; 4<\/sup> Department of Cardiovascular and Thoracic Surgery, University Hospital Mont-Godinne, Belgium; 5 <\/sup>Department of Vascular Surgery, University Hospital of Brussels, Belgium<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

12.45<\/span> Paper 3.4<\/span><\/td>\nBleeding risk of anticoagulants in the prevention of venous thromboembolism among Asians. NC Liew, L Lee<\/em><\/span><\/p>\n

Department of Surgery, University Putra Malaysia, Serdang, Malaysia<\/span><\/td>\n<\/tr>\n

13.00-14.00<\/span><\/td>\nLunch and visit to Exhibition\u00a0 |\u00a0 Judging ePresentations Session<\/span><\/p>\n

AGM of EVF (Members only)<\/span><\/td>\n<\/tr>\n

14.00-16.00<\/span><\/td>\nAbstract Session 4:<\/strong><\/span> Investigations (10 minute presentation, 5 minute discussion)<\/span><\/p>\n

Chair: Armando Mansilha (Portugal), Mark Whiteley (UK)<\/em><\/td>\n<\/tr>\n

14.00<\/span> Paper 4.1<\/span><\/td>\nPostural change of the saphenous diameter in chronic venous disease. SK Van der Velden, M DeMaeseneer, O Pichot, T Nijsten, R van den Bos <\/em><\/span><\/p>\n

Erasmus MC, Department of Dermatology, Rotterdam, The Netherlands<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

14.15<\/span> Paper 4.2<\/span><\/td>\nA body weight transfer manoeuvre with minimal ankle movement significantly outperforms the tip-toe manoeuvre in assessing calf muscle pump function. CR Lattimer1<\/sup>, E Kalodiki1<\/sup>, C Franceschi2<\/sup>, F Passariello 3<\/sup><\/em><\/span><\/p>\n

1<\/sup>Josef Pflug Vascular Laboratory, Ealing Hospital & Imperial College, London, UK; 2<\/sup> H\u00f4pital Paris Saint-Joseph, Paris, France; 3<\/sup> Vasculab Foundation ONLUS, Napoli, Italy<\/span><\/td>\n<\/tr>\n

14.30<\/span> Paper 4.3<\/span><\/td>\nQuantification of reflux volume on the great saphenous vein by duplex ultrasound in patients with primary varicosities. K Lobastov1,2<\/sup>, A Vorontsova1<\/sup>, A Bargandzhiya1<\/sup>, V Barinov1,2<\/sup>, L Laberko1<\/sup>, V Boyarintsev2<\/sup>, G Rodoman1<\/sup><\/em><\/span><\/p>\n

1<\/sup>The Pirogov\u2019s Russian National Research Medical University; 2<\/sup>Clinical Hospital no.1 of the President\u2019s Administration of Russian Federation, Moscow, Russia<\/span><\/td>\n<\/tr>\n

14.45<\/span> Paper 4.4<\/span><\/td>\nComparison of magnetic resonance venography and duplex scanning in the evaluation of post-thrombotic lesions of iliofemoral venous segment. M Kazakmurzaev, G Askerkhanov, M Makhatilov<\/em><\/span><\/p>\n

Medical centre named after R.P. Askerkhanov, Makhachkala, Russia<\/span><\/td>\n<\/tr>\n

15.00<\/span> Paper 4.5<\/span><\/td>\nConnexin expression in venous disease: A biomarker for venous ulceration.<\/span>\u00a0M Kanapathy1,2<\/sup>, R Simpson1<\/sup>, A Mosahebi1,2<\/sup>, D Baker1,3<\/sup>, D Becker4<\/sup>, T Richards1,3<\/sup><\/span><\/em><\/p>\n

1<\/sup> Division of Surgery and Interventional Science, University College London, UK; 2<\/sup> Department of Plastic Surgery, Royal Free Hospital, London, UK; 3<\/sup> Department of Vascular Surgery, Royal Free Hospital, London, UK; 4 <\/sup>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

15.15<\/span> Paper 4.6<\/span><\/td>\nDifferences in levels of markers of inflammation and endothelial damage between the blood from varicose veins and systemic blood. A Spirkoska, MK Jezovnik, P Poredos<\/em><\/span><\/p>\n

Department of Vascular Disease, University Medical Centre Ljubljana, Ljubljana, Slovenia<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

15.30<\/span> Paper 4.7<\/span><\/td>\nCancer-relation vein thrombosis: Prevalence, causes and diagnosis. V Khryshchanovich, S Kalinin<\/em><\/span><\/p>\n

Belarusian State Medical University, Minsk, Republic of Belarus<\/span><\/td>\n<\/tr>\n

15.45<\/span> Paper 4.8<\/span><\/td>\nWound healing disorders following endophlebectomy of the common femoral vein and its impact on the patency rates of venous recanalisation. A Gombert1<\/sup>, ME Barbati1<\/sup>, J Grommes1<\/sup>,\u00a0 RLM Kurstjens2<\/sup>, M. deWolf2<\/sup> , C. Wittens1<\/sup>, H. Jalaie1<\/sup><\/em><\/span><\/p>\n

European Vascular Center Aachen-Maastricht; 1<\/sup>Department of Vascular Surgery University Hospital Aachen, Germany; 2<\/sup> Department of Vascular Surgery University Hospital Maastricht, Netherlands<\/span><\/p>\n

Submitted for the EVF Prize<\/em><\/span><\/td>\n<\/tr>\n

16.00-16.30<\/span><\/td>\nRefreshments and visit to Exhibition\u00a0 |\u00a0 Poster Session<\/span><\/td>\n<\/tr>\n
16.30-17.45<\/span><\/td>\nEVF\/VF Prize Sessions<\/strong><\/span><\/p>\n

Chairmen: EVF, VF<\/span><\/p>\n

Chair: Andrew Bradbury (UK), Evgeny Shaydakov (Russia)<\/span><\/em><\/td>\n<\/tr>\n

16.30-17.00<\/span><\/td>\n2 Presentations from American Venous Forum (AVF)<\/span><\/td>\n<\/tr>\n
16.30 Paper Pr. 1<\/span>
\n<\/span><\/td>\n		Hybrid operative thrombectomy demonstrates non-inferiority versus percutaneous techniques for the treatment acute iliofemoral deep vein thrombosis. LE Rodriguez, R Figueroa-Vicente, A Aboukheir-Aboukheir, L Torruella-Bartolomei, J Martinez-Trabal<\/em> <\/span><\/p>\n

St. Lukes Memorial Hospital, Utica, NY, USA<\/span><\/td>\n<\/tr>\n

16.45 Paper Pr. 2<\/span>
\n<\/span><\/td>\n		Is routine follow-up surveillance of iliac vein stents for iliocaval venous obstruction necessary? R Abdul-Haqq, Z Novak, B Pearce, T Matthews, M Patterson, W Jordan, M Passman<\/em><\/span><\/p>\n

University of Alabama, Birmingham, AL, USA<\/span><\/td>\n<\/tr>\n

17.00-17.15<\/span><\/td>\n1 Presentation from American College of Phlebology (ACP)<\/span><\/td>\n<\/tr>\n
17.15 Paper Pr. 3<\/span>
\n<\/span><\/td>\n		Improvement in Varicose Vein Symptoms: Quantifying with the VVSymQ, an Electronic Patient-Reported Outcome (ePRO) Instrument. N Khilnan <\/em><\/span><\/p>\n

Interventional Radiology, NY Presbyterian Hosptial-Weill Conrell Medical College, New York, NY, USA<\/span><\/td>\n<\/tr>\n

17.15-17.45<\/span><\/td>\n2 Presentations from Japanese Society of Phlebology (JSP)<\/span><\/td>\n<\/tr>\n
17.15 Paper Pr. 4<\/span>
\n<\/span><\/td>\n		Thin-slice enhanced computed tomography for delineating the right adrenal vein before adrenal venous sampling. S Onozawa<\/em><\/span><\/p>\n

Department of Radiology, Oarai Kaigan Hospital, Ibaragi, Japan & Nippon Medical School, Tokyo, Japan<\/span><\/td>\n<\/tr>\n

17.30 Paper Pr. 5<\/span>
\n<\/span><\/td>\n		Involvement of myofibroblasts in the pathophysiology of secondary lymphoedema. M Sano<\/em><\/span><\/p>\n

Second Department of Surgery, Vascular Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan<\/span><\/td>\n<\/tr>\n

19.00<\/span><\/td>\nCongress Dinner, Royal College of Surgeons<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

SATURDAY 9 JULY 2016<\/strong><\/span><\/h2>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08.30-10.15<\/span><\/td>\nAbstract Session 5:<\/span> <\/strong>Compression, Leg Ulceration and DVT (10 minute presentation, 5 minute discussion)<\/span><\/p>\n

Chair: Mark Malouf (Australia), Abdusalam Abu-Own (UK)
\n<\/span><\/em><\/td>\n<\/tr>\n

08.30<\/span> Paper 5.1<\/span><\/td>\nInterface pressure, stiffness and haemodynamic effectiveness of a new compression device. G Mosti1<\/sup>, H Partsch2<\/sup>, J Damm3<\/sup>, T Lundh4<\/sup><\/em><\/span><\/p>\n

1<\/sup>Angiology Department, Clinica MD Barbantini, Lucca, Italy; 2<\/sup>Medical University of Vienna, Vienna, Austria; 3<\/sup>PressCise AB, Herrljunga, Sweden; 4<\/sup>Chalmers University of Technology, Gothenburg, Sweden<\/span><\/td>\n<\/tr>\n

08.45<\/span> Paper 5.2<\/span><\/td>\nA method to increase working compression pressure without changing resting pressure. J Damm1<\/sup>, T Lundh2<\/sup>, Hugo Partsch3<\/sup>, Giovanni Mosti4<\/sup><\/em><\/span><\/p>\n

1<\/sup>PressCise AB, Herrljunga, Sweden; 2<\/sup>Chalmers University of Technology, Gothenburg, Sweden; 3<\/sup>Medical University of Vienna, Vienna, Austria; 4<\/sup>Angiology Department, Clinica MD Barbantini, Lucca, Italy<\/span><\/td>\n<\/tr>\n

09.00<\/span> Paper 5.3<\/span><\/td>\nCompression film bandage added to medical compression stockings improves comfort and results of foam sclerotherapy. JC Ragg<\/em><\/span><\/p>\n

Angioclinic Vein Centers – Interventional Phlebology, Berlin \u2013 Munich, Germany,\u00a0 \u2013 Zurich, Switzerland<\/span><\/td>\n<\/tr>\n

09.15<\/span> Paper 5.4<\/span><\/td>\nRecalcitrant venous leg ulcers may heal by conservative outpatient treatment of venous disease even in the presence of concomitant arterial occlusive disease. G Mosti1<\/sup>, A Cavezzi2<\/sup>, H Partsch3<\/sup><\/em><\/span><\/p>\n

1<\/sup>Angiology Department, MD Barbantini Hospital, Lucca, Italy; 2<\/sup>Eurocenter Venalinfa, S. Benedetto del Tronto (AP), Italy; 3<\/sup>Medical University of Vienna, Vienna, Austria<\/span><\/td>\n<\/tr>\n

09.30<\/span> Paper 5.5<\/span><\/td>\nCharacteristics of isolated calf vein thrombos in current clinical practice. Y Hosoi, M Nunokawa, T Ikezoe, Y Nishino, H Kubota<\/em><\/span><\/p>\n

Department of Cardiovascular Surgery, Kyorin University, Tokyo, Japan<\/span><\/td>\n<\/tr>\n

09.45<\/span> Paper 5.6<\/span><\/td>\nComparison between frequency of calf DVT after earthquakes in Japan and Italy. K Hanzawa1<\/sup>, T Okamoto1<\/sup>, K Aoki1<\/sup>, O Namura1<\/sup>, M Tsuchida1<\/sup>, S Stipa2<\/sup>, M Lugli3<\/sup><\/em><\/span><\/p>\n

1<\/sup>Niigata University Graduate School Of Medicine, Niigata, Japan; 2<\/sup>Finale Emilia, Modena, Italy; 3<\/sup>Hesperia Hospital, Modena, Italy<\/span><\/td>\n<\/tr>\n

10.00<\/span> Paper 5.7<\/span><\/td>\nPrevalence of chronic venous disease (CVD) and restless leg syndrome (RLS) in general population (epidemiological study). A Sukhanov, K Mazaishvili, T Khlevtova, V Angelova, S Akimov, V Semkin, R Mamedov<\/em><\/span><\/p>\n

Phlebological Centre Antireflux, Moscow, Russia<\/span><\/td>\n<\/tr>\n

10.15-10.45<\/span><\/td>\nRefreshments and visit to Exhibition\u00a0 |\u00a0 Poster Session<\/span><\/td>\n<\/tr>\n
10.45-11.45<\/span><\/td>\nAbstract Session 6:<\/span><\/strong> Deep Venous Reconstruction (10 minute presentation, 5 minute discussion)<\/span><\/p>\n

Chair: Michel Perrin (France), Alun Davies (UK)
\n<\/span><\/em><\/td>\n<\/tr>\n

10.45<\/span> Paper 6.1<\/span><\/td>\nPelvic vein embolization under local anaesthetic is feasible and safe in an outpatient clinic setting.\u00a0 18 months\u2019 experience of a new service. SJ Bishop, EL Davis, TJ Fernandez-Hart, P Diwakar, D Beckett, MS Whiteley<\/em><\/span><\/p>\n

The Whiteley Clinic, London, UK<\/span><\/td>\n<\/tr>\n

11.00<\/span> Paper 6.2<\/span><\/td>\nNeovalve construction surgery in postthrombotic syndrome and primary deep vein insufficiency. Y Hoshino1<\/sup>, S Hoshino2<\/sup><\/em><\/span><\/p>\n

1<\/sup>Fukuoka Sanno Hospital, Vascular Surgery, Fukuoka, Japan; 2<\/sup>Fukushima Diichi Hospital, Fukushima, Japan<\/span><\/td>\n<\/tr>\n

11.15<\/span> Paper 6.3<\/span><\/td>\nVenous stent stability index (VSSI): A guide for iliac vein stent sizing and prevention of migration in the treatment of symptomatic iliac compression. PE Thorpe, AP Chinubhai<\/em><\/span><\/p>\n

Arizona Heart Hospital, Phoenix, Arizona, USA<\/span><\/p>\n

Veniti Inc., Fremont, California, USA<\/span><\/td>\n<\/tr>\n

11.30<\/span> Paper 6.4<\/span><\/td>\nSystematic review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. GS Sfyroeras1<\/sup>, CN Antonopoulos1<\/sup>, G Mantas1<\/sup>, KG Moulakakis1<\/sup>, JD Kakisis1<\/sup>, E Brountzos2<\/sup>, CR Lattimer3<\/sup>, G Geroulakos1<\/sup>,3<\/sup><\/em><\/span><\/p>\n

1<\/sup>Department of Vascular Surgery; 2<\/sup>2nd Laboratory of Radiology, University of Athens Medical School, Attikon University Hospital, Athens, Greece; 3<\/sup>Department of Surgery and Cancer, Imperial College, London, UK<\/span><\/td>\n<\/tr>\n

11.45-12.45<\/span><\/td>\nDidactic Session 6:<\/strong> Deep venous interventions<\/span><\/p>\n

Chairmen: Niels Baekgaard (Denmark), Stephen Black (UK)<\/span><\/em><\/td>\n<\/tr>\n

11.45<\/span><\/td>\nAssessing outcome after venous stenting \u2013 quality of life is more important than patency. Manj Gohel (UK)<\/em><\/span><\/td>\n<\/tr>\n
11.55<\/span><\/td>\nHaematological management post stenting \u2013 what anticoagulant and for how long. Prakash Saha (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.05<\/span><\/td>\nDeep venous valve technologies: horizon scanning. Hayley Moore (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.15<\/span><\/td>\nPopliteal vein entrapment: a forgotten entity. Alun Davies (UK)<\/em><\/span><\/td>\n<\/tr>\n
12.25<\/span><\/td>\nDiscussion<\/span><\/strong><\/td>\n<\/tr>\n
12.45<\/span><\/td>\nEnd of Meeting<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Provisional Scientific Programme 17th Meeting of the European Venous Forum In collaboration with the UK Venous Forum, Royal Society of Medicine London, UK, 7- 9 July 2016 Click here to download the Programme. Click here to download the Programme\/Book of Abstracts.   THURSDAY 7 JULY 2016   08.30-10.30 Abstract Session \u2026 Continue reading → <\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-onecolumn.php","meta":{"_exactmetrics_skip_tracking":false,"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-2083","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/comments?post=2083"}],"version-history":[{"count":3,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2083\/revisions"}],"predecessor-version":[{"id":2107,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2083\/revisions\/2107"}],"wp:attachment":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/media?parent=2083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}